1.Advances in epigenetics in ischemic stroke.
Dan-Hong LIU ; Xia-Jun XIONG ; Jun LIAO ; Zhi-Gang MEI ; Jin-Wen GE ; Meng-Zhen WEI
China Journal of Chinese Materia Medica 2022;47(17):4551-4559
Ischemic stroke is one of the main causes of death and long-term disability worldwide, which seriously affects the quality of life of patients and brings a heavy economic burden to families and society. Epidemiological studies have shown that stroke has become the second leading cause of death and major disabling disease in the world, with the characteristics of high morbidity, high recurrence, and high mortality. Epigenetic mechanism is the molecular process where gene expression and function in each cell are dynamically regulated and interconnected and a biological mechanism that changes genetic performance without changing the DNA sequence, including DNA methylation, histone modifications, and non-coding RNA. However, the research on epigenetics is currently focused on other diseases such as tumors. Recent studies have found that epigenetics has received extensive attention in the past few decades as a key factor involved in the pathophysiological process of ischemic stroke. The present study introduced the mediation of epigenetics in the induction of stroke, summarized the potential drug targets for these mechanisms in the treatment of stroke, and further explored the significance of traditional Chinese medicine(TCM) against cerebral ischemia injury based on TCM classification of stroke.
DNA Methylation
;
Epigenesis, Genetic
;
Humans
;
Ischemic Stroke/genetics*
;
Quality of Life
;
RNA, Untranslated/metabolism*
;
Stroke/genetics*
2.A Nested Case-Control Study to Explore the Association between Immunoglobulin G N-glycans and Ischemic Stroke.
Bi Yan WANG ; Man Shu SONG ; Jie ZHANG ; Xiao Ni MENG ; Wei Jia XING ; You Xin WANG
Biomedical and Environmental Sciences 2023;36(5):389-396
OBJECTIVE:
This study prospectively investigates the association between immunoglobulin G (IgG) N-glycan traits and ischemic stroke (IS) risk.
METHODS:
A nested case-control study was conducted in the China suboptimal health cohort study, which recruited 4,313 individuals in 2013-2014. Cases were identified as patients diagnosed with IS, and controls were 1:1 matched by age and sex with cases. IgG N-glycans in baseline plasma samples were analyzed.
RESULTS:
A total of 99 IS cases and 99 controls were included, and 24 directly measured glycan peaks (GPs) were separated from IgG N-glycans. In directly measured GPs, GP4, GP9, GP21, GP22, GP23, and GP24 were associated with the risk of IS in men after adjusting for age, waist and hip circumference, obesity, diabetes, hypertension, and dyslipidemia. Derived glycan traits representing decreased galactosylation and sialylation were associated with IS in men (FBG2S2/(FBG2 + FBG2S1 + FBG2S2): odds ratio ( OR) = 0.92, 95% confidence interval ( CI): 0.87-0.97; G1 n: OR = 0.74, 95% CI: 0.63-0.87; G0 n: OR = 1.12, 95% CI: 1.03-1.22). However, these associations were not found among women.
CONCLUSION
This study validated that altered IgG N-glycan traits were associated with incident IS in men, suggesting that sex discrepancies might exist in these associations.
Male
;
Humans
;
Female
;
Immunoglobulin G/metabolism*
;
Ischemic Stroke
;
Case-Control Studies
;
Cohort Studies
;
Glycosylation
;
Polysaccharides
3.Research advances in prevention and treatment of cerebral ischemia-reperfusion injury by targeting mitochondrial quality control.
Xuan WEI ; Ji-Yong LIU ; Wen-Li ZHANG ; Zhi-Gang MEI
China Journal of Chinese Materia Medica 2022;47(16):4305-4313
Cerebral ischemia-reperfusion injury(CIRI) is an important factor hindering the recovery of ischemic stroke patients after blood flow recanalization. Mitochondria, serving as the "energy chamber" of cells, have multiple important physiological functions, such as supplying energy, metabolizing reactive oxygen species, storing calcium, and mediating programmed cell death. During CIRI, oxidative stress, calcium overload, inflammatory response, and other factors can easily lead to neuronal mitochondrial dyshomeostasis, which is the key pathological link leading to secondary injury. As reported, the mitochondrial quality control(MQC) system, mainly including mitochondrial biosynthesis, kinetics, autophagy, and derived vesicles, is an important endogenous mechanism to maintain mitochondrial homeostasis and plays an important protective role in the damage of mitochondrial structure and function caused by CIRI. This paper reviewed the mechanism of MQC and the research progress on MQC-targeting therapy of CIRI in recent 10 years to provide theoretical references for exploring new strategies for the prevention and treatment of ischemic stroke with traditional Chinese medicine.
Brain Ischemia/prevention & control*
;
Calcium/metabolism*
;
Humans
;
Ischemic Stroke
;
Mitochondria/pathology*
;
Reactive Oxygen Species/metabolism*
;
Reperfusion Injury/prevention & control*
4.Role of SIRTs in cerebral ischemia reperfusion injury and targeted intervention of Chinese medicine.
Guang-Shan HUANG ; Xuan WEI ; Kai YANG ; Ji-Yong LIU ; Jin-Wen GE ; Zhi-Gang MEI
China Journal of Chinese Materia Medica 2022;47(20):5406-5417
Cerebral ischemia-reperfusion injury(CIRI) is a complex cascade process and seriously hinders the recovery of patients with acute ischemic stroke, which has become an urgent public health issue to be addressed. Silent information regulators(SIRTs) are a family of nicotinamide adenine dinucleotide(NAD~+)-dependent deacetylases, capable of deacylating the histone and non-histone lysine groups. Accumulating evidence has demonstrated that SIRTs are able to regulate the pathological processes such as oxidative stress, inflammatory response, mitochondrial dysfunction, and programmed cell death of CIRI through post-translational deacetylation, and exert the neuroprotection function. In this study, we reviewed the papers about the role and regulatory mechanisms of SIRTs in the pathological process of CIRI published in the past decade. Further, we summarized the research advance in the prevention and treatment of CIRI with Chinese medicine targeting SIRTs and the related signaling pathways. This review will provide new targets and theoretical support for the clinical application of Chinese medicine in treating CIRI during the occurrence of ischemic stroke.
Humans
;
Brain Ischemia/therapy*
;
Ischemic Stroke/therapy*
;
Medicine, Chinese Traditional
;
Oxidative Stress
;
Reperfusion Injury/therapy*
;
Sirtuins/metabolism*
5.Single-Cell Mapping of Brain Myeloid Cell Subsets Reveals Key Transcriptomic Changes Favoring Neuroplasticity after Ischemic Stroke.
Fangxi LIU ; Xi CHENG ; Chuansheng ZHAO ; Xiaoqian ZHANG ; Chang LIU ; Shanshan ZHONG ; Zhouyang LIU ; Xinyu LIN ; Wei QIU ; Xiuchun ZHANG
Neuroscience Bulletin 2024;40(1):65-78
Interactions between brain-resident and peripheral infiltrated immune cells are thought to contribute to neuroplasticity after cerebral ischemia. However, conventional bulk sequencing makes it challenging to depict this complex immune network. Using single-cell RNA sequencing, we mapped compositional and transcriptional features of peri-infarct immune cells. Microglia were the predominant cell type in the peri-infarct region, displaying a more diverse activation pattern than the typical pro- and anti-inflammatory state, with axon tract-associated microglia (ATMs) being associated with neuronal regeneration. Trajectory inference suggested that infiltrated monocyte-derived macrophages (MDMs) exhibited a gradual fate trajectory transition to activated MDMs. Inter-cellular crosstalk between MDMs and microglia orchestrated anti-inflammatory and repair-promoting microglia phenotypes and promoted post-stroke neurogenesis, with SOX2 and related Akt/CREB signaling as the underlying mechanisms. This description of the brain's immune landscape and its relationship with neurogenesis provides new insight into promoting neural repair by regulating neuroinflammatory responses.
Humans
;
Ischemic Stroke
;
Brain/metabolism*
;
Macrophages
;
Brain Ischemia/metabolism*
;
Microglia/metabolism*
;
Gene Expression Profiling
;
Anti-Inflammatory Agents
;
Neuronal Plasticity/physiology*
;
Infarction/metabolism*
6.Functionalized exosome-loaded ginsenoside Rg1 for the treatment of ischemic stroke.
Huijun LUO ; Zhixuan HUANG ; Yijie SHI
Chinese Journal of Biotechnology 2023;39(1):275-285
The aim of this study was to investigate the therapeutic effects and potential mechanism of c(RGDyK) peptide modified mesenchymal stem cell exosomes loaded with ginsenoside Rg1 (G-Rg1) on ischemic stroke. Thread-tying method was used to establish SD rats transient middle cerebral occlusion model (tMCAO). The model rats were randomly divided into tMCAO group, Exo group, free G-Rg1 group, Exo-Rg1 group and cRGD-Exo-Rg1 group, and sham group was used as control. The infarct volume was measured by 2, 3, 5-triphenyltetrachloride (TTC) staining, the changes of neuron and endothelium were observed by immunofluorescence, and the expression of related proteins was detected by Western blotting. The results showed that cRGD-Exo-Rg1 up-regulated the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factors (HIF-1α) by activating PI3K/AKT pathway, thus promoting angiogenesis and neurogenesis, effectively reducing the volume of cerebral infarction and improving neural function. In addition, the delivery of cRGD-Exo-Rg1 to ischemic brain tissue up-regulated the expression of occludin and claudin-5, and reduced the injury of blood-brain barrier. Taken together, cRGD-Exo-Rg1 was effective in the treatment of ischemic stroke by promoting angiogenesis and neurogenesis, which provided experimental evidence for the potential clinical benefits of other neuroprotective therapies.
Rats
;
Animals
;
Ischemic Stroke/drug therapy*
;
Rats, Sprague-Dawley
;
Phosphatidylinositol 3-Kinases
;
Vascular Endothelial Growth Factor A/metabolism*
;
Exosomes/metabolism*
;
Ginsenosides/therapeutic use*
7.Changes in Gene Expression in the Rat Hippocampus after Focal Cerebral Ischemia.
Jun Young CHUNG ; Jae Woo YI ; Sung Min KIM ; Young Jin LIM ; Joo Ho CHUNG ; Dae Jean JO
Journal of Korean Neurosurgical Society 2011;50(3):173-178
OBJECTIVE: The rat middle cerebral artery thread-occlusion model has been widely used to investigate the pathophysiological mechanisms of stroke and to develop therapeutic treatment. This study was conducted to analyze energy metabolism, apoptotic signal pathways, and genetic changes in the hippocampus of the ischemic rat brain. METHODS: Focal transient cerebral ischemia was induced by obstructing the middle cerebral artery for two hours. After 24 hours, the induction of ischemia was confirmed by the measurement of infarct size using 2,3,5-triphenyltetrazolium chloride staining. A cDNA microarray assay was performed after isolating the hippocampus, and was used to examine changes in genetic expression patterns. RESULTS: According to the cDNA microarray analysis, a total of 1,882 and 2,237 genes showed more than a 2-fold increase and more than a 2-fold decrease, respectively. When the genes were classified according to signal pathways, genes related with oxidative phosphorylation were found most frequently. There are several apoptotic genes that are known to be expressed during ischemic brain damage, including Akt2 and Tnfrsf1a. In this study, the expression of these genes was observed to increase by more than 2-fold. As energy metabolism related genes grew, ischemic brain damage was affected, and the expression of important genes related to apoptosis was increased/decreased. CONCLUSION: Our analysis revealed a significant change in the expression of energy metabolism related genes (Atp6v0d1, Atp5g2, etc.) in the hippocampus of the ischemic rat brain. Based on this data, we feel these genes have the potential to be target genes used for the development of therapeutic agents for ischemic stroke.
Animals
;
Apoptosis
;
Brain
;
Brain Ischemia*
;
Energy Metabolism
;
Gene Expression*
;
Hippocampus*
;
Ischemia
;
Ischemic Attack, Transient
;
Middle Cerebral Artery
;
Oligonucleotide Array Sequence Analysis
;
Oxidative Phosphorylation
;
Rats*
;
Signal Transduction
;
Stroke
8.The Circadian System Is Essential for the Crosstalk of VEGF-Notch-mediated Endothelial Angiogenesis in Ischemic Stroke.
Yuxing ZHANG ; Xin ZHAO ; Chun GUO ; Ying ZHANG ; Fukang ZENG ; Qian YIN ; Zhong LI ; Le SHAO ; Desheng ZHOU ; Lijuan LIU
Neuroscience Bulletin 2023;39(9):1375-1395
Ischemic stroke is a major public health problem worldwide. Although the circadian clock is involved in the process of ischemic stroke, the exact mechanism of the circadian clock in regulating angiogenesis after cerebral infarction remains unclear. In the present study, we determined that environmental circadian disruption (ECD) increased the stroke severity and impaired angiogenesis in the rat middle cerebral artery occlusion model, by measuring the infarct volume, neurological tests, and angiogenesis-related protein. We further report that Bmal1 plays an irreplaceable role in angiogenesis. Overexpression of Bmal1 promoted tube-forming, migration, and wound healing, and upregulated the vascular endothelial growth factor (VEGF) and Notch pathway protein levels. This promoting effect was reversed by the Notch pathway inhibitor DAPT, according to the results of angiogenesis capacity and VEGF pathway protein level. In conclusion, our study reveals the intervention of ECD in angiogenesis in ischemic stroke and further identifies the exact mechanism by which Bmal1 regulates angiogenesis through the VEGF-Notch1 pathway.
Rats
;
Animals
;
Vascular Endothelial Growth Factor A/pharmacology*
;
Brain Ischemia/metabolism*
;
Ischemic Stroke
;
Signal Transduction
;
ARNTL Transcription Factors/pharmacology*
;
Neovascularization, Physiologic/physiology*
9.Danshen-Chuanxiongqin Injection attenuates cerebral ischemic stroke by inhibiting neuroinflammation via the TLR2/ TLR4-MyD88-NF-κB Pathway in tMCAO mice.
Xiao-Jing XU ; Jin-Bo LONG ; Kai-Yu JIN ; Li-Bing CHEN ; Xiao-Yan LU ; Xiao-Hui FAN
Chinese Journal of Natural Medicines (English Ed.) 2021;19(10):772-783
Danshen-Chuanxiongqin Injection (DCI) is a commonly used traditional Chinese medicine for the treatment of cerebral ischemic stroke in China. However, its underlying mechanisms remain completely understood. The current study was designed to explore the protective mechanisms of DCI against cerebral ischemic stroke through integrating whole-transcriptome sequencing coupled with network pharmacology analysis. First, using a mouse model of cerebral ischemic stroke by transient middle cerebral artery occlusion (tMCAO), we found that DCI (4.10 mL·kg
Brain Ischemia/genetics*
;
Drugs, Chinese Herbal
;
Humans
;
Infarction, Middle Cerebral Artery/genetics*
;
Ischemic Stroke
;
Myeloid Differentiation Factor 88/genetics*
;
NF-kappa B/metabolism*
;
Stroke/genetics*
;
Toll-Like Receptor 2
;
Toll-Like Receptor 4/metabolism*
10.Effect and mechanism of Zuogui Pills on neural function recovery in ischemic stroke mice based on OPN/IGF-1/mTOR.
Yan LIU ; Chun-Chen GAO ; Li LI ; Dan WU ; Yu-Jun CONG ; Qing-Hua FENG ; Ming-Hua WU ; Wen-Lei LI
China Journal of Chinese Materia Medica 2023;48(19):5250-5258
To explore the effect and mechanism of Zuogui Pills in promoting neural tissue recovery and functional recovery in mice with ischemic stroke. Male C57BL/6J mice were randomly divided into a sham group, a model group, and low-, medium, and high-dose Zuogui Pills groups(3.5, 7, and 14 g·kg~(-1)), with 15 mice in each group. The ischemic stroke model was established using photochemical embolization. Stiker remove and irregular ladder walking behavioral tests were conducted before modeling and on days 7, 14, 21, and 28 after medication. Triphenyl tetrazolium chloride(TTC) staining was performed on day 3 after modeling, and T2-weighted imaging(T2WI) and diffusion-weighted imaging(DWI) were performed on day 28 after medication to evaluate the extent of brain injury. Hematoxylin-eosin(HE) staining was performed to observe the histology of the cerebral cortex. Axonal marker proteins myelin basic protein(MBP), growth-associated protein 43(GAP43), mammalian target of rapamycin(mTOR), and its downstream phosphorylated s6 ribosomal protein(p-S6), as well as mechanism-related proteins osteopontin(OPN) and insulin-like growth factor 1(IGF-1), were detected using immunofluorescence and Western blot. Zuogui Pills had a certain restorative effect on the neural function impairment caused by ischemic stroke in mice. TTC staining showed white infarct foci in the sensory-motor cortex area, and T2WI imaging revealed cystic necrosis in the sensory-motor cortex area. The Zuogui Pills groups showed less brain tissue damage, fewer scars, and more capillaries. The number of neuronal axons in those groups was higher than that in the model group, and neuronal activity was stronger. The expression of GAP43, OPN, IGF-1, and mTOR proteins in the Zuogui Pills groups was higher than that in the model group. In summary, Zuogui Pills can promote the recovery of neural function and axonal growth in mice with ischemic stroke, and its mechanism may be related to the activation of the OPN/IGF-1/mTOR signaling pathway.
Mice
;
Animals
;
Male
;
Ischemic Stroke
;
Recovery of Function/physiology*
;
Insulin-Like Growth Factor I/pharmacology*
;
Mice, Inbred C57BL
;
TOR Serine-Threonine Kinases/metabolism*
;
Stroke/drug therapy*
;
Brain Ischemia/drug therapy*
;
Mammals/metabolism*